Cm-p5 [E4C, H8C]

General Information


DRACP ID  DRACP00924

Peptide Name   Cm-p5 [E4C, H8C]

Sequence  SRSCLIVCQRLF

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
THP-1 Childhood acute monocytic leukemia; Acute monoblastic/monocytic leukemia Leukemia Not active up to 300 µg/ml PrestoBlue cell viability reagent overnight 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00924

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys4<--->Cys8

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C61H105N19O16S2

Absent amino acids  ADEGHKMNPTWY

Common amino acids  CLRS

Mass  162113

Pl  8.83

Basic residues  2

Acidic residues  0

Hydrophobic residues  5

Net charge  2

Boman Index  -1784

Hydrophobicity  83.33

Aliphatic Index  121.67

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  125

Absorbance 280nm  11.36

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31763531

Title  Design of a Helical-Stabilized, Cyclic, and Nontoxic Analogue of the Peptide Cm-p5 With Improved Antifungal Activity.

Doi 10.1021/acsomega.9b02201

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.